A Bioequivalence Study Comparing Two Different Tafamidis Formulations
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
Each subject will be given tafamidis. After swallowing a single tafamidis capsule, tafamidis
blood concentrations will be measured periodically for one week. After about 20 days,
subjects will take a different form of tafamidis capsule and the process repeated. Tafamidis
concentrations from the two different formulations will be compared to determine if they are
approximately the same.